| Joel Wiszniak, MD | |
|
18205 Biscayne Blvd, Suite 2217, Aventura, FL 33160-2106 | |
| (305) 935-9922 | |
| (305) 935-9902 |
| Full Name | Joel Wiszniak |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 46 Years |
| Location | 18205 Biscayne Blvd, Aventura, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861413395 | NPI | - | NPPES |
| 0479110 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | ME53127 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Skin And Cancer Associates | 1759284847 | 64 |
News Archive
Frequent measurement of blood flow changes could improve the ability of health care providers to diagnose and treat patients with vascular conditions, such as those associated with diabetes and high blood pressure.
OVATION Pharmaceuticals, Inc. announced the initiation of a pivotal Phase III clinical trial evaluating clobazam, a unique 1,5 benzodiazapine with significant anticonvulsant properties, as adjunctive treatment for patients with Lennox-Gastaut syndrome (LGS), one of the most severe forms of childhood epilepsy that frequently persists into adulthood.
Exposure to fluoride may lower children's intelligence says a study pre-published in Environmental Health Perspectives, a publication of the National Institute of Environmental Health Sciences (online December 17, 2010).
More than ever before, Alzheimer's researchers understand that a variety of approaches will be needed - most likely used in combination - for effective treatment of the disease.
› Verified 1 days ago
| Entity Name | Skin And Cancer Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427017292 PECOS PAC ID: 1759284847 Enrollment ID: O20040128000060 |
News Archive
Frequent measurement of blood flow changes could improve the ability of health care providers to diagnose and treat patients with vascular conditions, such as those associated with diabetes and high blood pressure.
OVATION Pharmaceuticals, Inc. announced the initiation of a pivotal Phase III clinical trial evaluating clobazam, a unique 1,5 benzodiazapine with significant anticonvulsant properties, as adjunctive treatment for patients with Lennox-Gastaut syndrome (LGS), one of the most severe forms of childhood epilepsy that frequently persists into adulthood.
Exposure to fluoride may lower children's intelligence says a study pre-published in Environmental Health Perspectives, a publication of the National Institute of Environmental Health Sciences (online December 17, 2010).
More than ever before, Alzheimer's researchers understand that a variety of approaches will be needed - most likely used in combination - for effective treatment of the disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joel Wiszniak, MD 18205 Biscayne Blvd, Suite 2217, Aventura, FL 33160-2106 Ph: (305) 935-9922 | Joel Wiszniak, MD 18205 Biscayne Blvd, Suite 2217, Aventura, FL 33160-2106 Ph: (305) 935-9922 |
News Archive
Frequent measurement of blood flow changes could improve the ability of health care providers to diagnose and treat patients with vascular conditions, such as those associated with diabetes and high blood pressure.
OVATION Pharmaceuticals, Inc. announced the initiation of a pivotal Phase III clinical trial evaluating clobazam, a unique 1,5 benzodiazapine with significant anticonvulsant properties, as adjunctive treatment for patients with Lennox-Gastaut syndrome (LGS), one of the most severe forms of childhood epilepsy that frequently persists into adulthood.
Exposure to fluoride may lower children's intelligence says a study pre-published in Environmental Health Perspectives, a publication of the National Institute of Environmental Health Sciences (online December 17, 2010).
More than ever before, Alzheimer's researchers understand that a variety of approaches will be needed - most likely used in combination - for effective treatment of the disease.
› Verified 1 days ago
Dr. Janet Carol Teltscher, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 21150 Biscayne Blvd, Ste 102, Aventura, FL 33180 Phone: 305-933-3395 Fax: 305-935-6248 | |
Loretta M Ciraldo, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 18851 Ne 29th Ave, Suite 768, Aventura, FL 33180 Phone: 305-749-3135 Fax: 305-749-3136 | |
Mark Steven Nestor, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2925 Aventura Blvd, Ste 205, Aventura, FL 33180 Phone: 305-933-6716 Fax: 305-933-6720 | |
Donna Bilu Martin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2999 Ne 191st Street, Ph1, Aventura, FL 33180 Phone: 305-933-1151 Fax: 305-933-8055 | |
Carlos Cohen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2999 Ne 191st St Ste 260, Aventura, FL 33180 Phone: 954-436-2200 Fax: 954-436-2262 | |
Newsha Lajevardi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2801 Ne 213th St Ste 1005, Aventura, FL 33180 Phone: 305-330-9933 Fax: 305-250-2610 | |
Dr. Brian Berman, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2925 Aventura Boulevard, S. 205, Aventura, FL 33180 Phone: 305-933-6716 Fax: 305-933-6720 |